Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Skin reactions from cancer treatments might predict how well the treatments work.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Too much vitamin A can cause liver damage and skin issues.

Eclipta alba (Bhringraj) helps protect the liver and promotes hair growth.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

High doses of some selenium supplements caused liver and reproductive harm in rats.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

ING5 is crucial for stem cell maintenance and preventing certain cancers.